| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |